Health
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro has improved in the U.S. after months of widespread […]
Read More
Moderna stock falls 10% as hefty Covid vaccine write-downs drive big loss
Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product. Moderna’s total revenue for the period topped Wall Street’s expectations, even amid plummeting demand for its shot. Its outlook for next year, however, came in […]
Read More
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due to charges primarily related to its recent acquisitions. Here’s […]
Read More
The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the three months ended Sept. 30 rose 15.9% to $26.42 […]
Read More
New lung cancer screening guidelines expand who should get tested annually
amnat jomjun | iStock | Getty Images Only a fraction of people at high risk for lung cancer are getting screened for the disease even though it kills more in the United States than breast, colorectal and prostate cancers combined. New American Cancer Society guidelines will allow millions more to become eligible for regular scans […]
Read More
Doctors have a new way to scrub personal information from internet after spike in harassment
Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE Doximity, the medical website that’s used by more than 80% of U.S. doctors, is now trying to protect its millions of members after a spike in harassment that started during the Covid pandemic. The 13-year-old company has introduced a free […]
Read More
CVS results top expectations, lifted by strong health services revenue
A woman walks past a CVS Pharmacy in Washington, D.C., on Nov. 2, 2022. Brendan Smialowski | AFP | Getty Images CVS on Wednesday reported third-quarter adjusted earnings and revenue that topped Wall Street’s expectations, lifted in part by strong revenue from the company’s health services business. CVS booked sales of $89.76 billion for the […]
Read More
Some pharmacy staff from Walgreens, other chains are walking out again — here’s what you need to know
A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Brian Snyder | Reuters Some pharmacy staff from Walgreens and other drugstore chains are planning to walk out next week in the latest pushback against what they call unsafe working conditions that put both employees and patients at […]
Read More
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don’t expect this duopoly to end soon, analysts say. But other companies — both big and small — are hoping to grab a piece of this lucrative market. In a research note, Piper Sandler analyst Yasmeen Rahimi said the firm is tracking more […]
Read More
We had a busy week of trades in an oversold market. Here’s the day-by-day breakdown
Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of our tech giants after it reported a stellar quarter […]
Read More